Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...

Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...

Report on how AI is driving market transformation - The global fetal bovine serum market size is estimated to grow by USD 364 ...

‘Chronos-PD’ is looking for biological signals that could indicate ... tools and disease-modifying therapiesPart of broad Grifols program to find disease-revealing clues in more than 100 ...

Grifols has been awarded a $21m grant from the Michael J Fox Foundation to find plasma biomarkers to predict Parkinson's years before symptoms start. Join the conversation, on Tuesday 28th January ...

Spanish pharma Grifols is leveraging its massive collection of plasma samples to look for early biomarkers of Parkinson’s disease (PD) thanks to a $21 million grant from the Michael J.

Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify plasma-based ...

Hidradenitis suppurativa is managed with biologics like adalimumab and secukinumab, approved for moderate-to-severe cases. Adalimumab, a TNF-α inhibitor, was FDA-approved in 2015, while ...

A trade group representing thousands of football coaches at all levels of the sport has turned to K Street for help squeezing ...

The refractory gout market is growing because of the rising prevalence of gout brought on by aging populations and changes in ...